News and Trends 15 Apr 2021
Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
…companies tap to identify personalized targets for individuals in clinical trials. Earlier this month, myNEO announced a partnership with sequencing company OncoDNA to design personalized vaccines against cancer neoantigens based…